1. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer
   Xiao Zhang et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
2. Integrative network analysis identifies potential targets and drugs for ovarian cancer
   Tianyu Zhang et al, 2020, BMC Medical Genomics CrossRef
3. Oxidative Stress Induces Chondrocyte Apoptosis through Caspase-Dependent and Caspase-Independent Mitochondrial Pathways and the Antioxidant Mechanism of Angelica Sinensis Polysaccharide
   Chao Zhuang et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
4. Aspirin Suppressed PD-L1 Expression through Suppressing KAT5 and Subsequently Inhibited PD-1 and PD-L1 Signaling to Attenuate OC Development
   Xiyun Xiao et al, 2022, Journal of Oncology CrossRef
5. Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model
   Geny del Socorro Fierros Zárate et al, 2023, Gynecologic and Obstetric Investigation CrossRef
6. Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act
   Roi Tschernichovsky et al, 2017, The Oncologist CrossRef
7. Aspirin induces Beclin-1-dependent autophagy of human hepatocellular carcinoma cell
   Zhenjun Huang et al, 2018, European Journal of Pharmacology CrossRef
8. Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system
   Y. O. Tabaliuk et al, 2021, Visnik ukrains'kogo tovaristva genetikiv i selekcioneriv CrossRef
9. Old wine in new bottles: Drug repurposing in oncology
   Michał Antoszczak et al, 2020, European Journal of Pharmacology CrossRef